Regulated information

Continued sales growth driven by sustained organic growth

April 22, 2010 (Lure, France) - Vétoquinol recorded a significant increase in sales in the first quarter of 2010, driven by sustained organic growth and the contribution of its Indian acquisition.

Departure of Pierre Konareff

April 14, 2010 (Lure, France) – The Vétoquinol Group today announces the departure of Pierre
Konareff, Group Director of Finance and Legal Affairs, because of differences concerning his
position in the Group. Pierre Konareff joined Vétoquinol in July 2008.

2009 annual earnings

March 31, 2010 – (Lure, France) – Vétoquinol’s Board of Directors, meeting on March 11, 2010, reviewed the Group’s business and approved its 2009 financial statements.

Redemption of tranche A bonds

February 26, 2010 (Lure, France) - Following the decision of Soparfin (family holding Etienne Frechin) not to convert the tranche A convertible bonds when they reach maturity on February 27, 2010, Vétoquinol has redeemed the bonds.

Strong growth in 2009 Revenues: +7.6%

January 20, 2010 (Lure, France) - Vétoquinol recorded strong sales growth in 2009, despite an unfavourable exchange rate effect. The strength in sales is explained to a large extent by the contribution of acquisitions in Italy and India and by the resumption of organic growth, which held firm in the second half of 2009 despite the continuing weakness in the general economy. Revenues increased in all therapeutic classes and all geographic regions.

VÉTOQUINOL and JANSSEN ANIMAL HEALTH finalize an agreement for the exclusive distribution of SUROLAN® in the United States

January 14, 2010 (Lure, France) – As part of its strategy of expanding its sales in the American market, Vétoquinol is pleased to announce an agreement with Janssen Animal Health to distribute Surolan® in the United States, following its approval by the FDA in December 2009. Surolan® is a leading example of Vétoquinol’s strategic focus on anti-infective agents and its success in this area. Surolan® has an excellent reputation in Europe, where it has been a great success.

Matthieu Frechin named Managing Director of Vétoquinol

December 14, 2009 (Lure, France) – The Board of Directors of Vétoquinol, at its December 10
meeting, has named Matthieu Frechin Managing Director of the Vétoquinol Group, replacing
Etienne Frechin. He will be seconded by Dominique Henryon, Deputy General Manager.
Etienne Frechin will give up all operating functions but will continue to serve as Chairman of
Vétoquinol’s Board of Directors.

Rapport du président sur le fonctionnement du conseil d’administration et sur le contrôle des procédures internes

En application de l’article L. 225-37 du Code de commerce, Monsieur Etienne Frechin, Président-Directeur Général du Groupe Vétoquinol, rend compte dans le cadre du présent rapport « des conditions de préparation et d’organisation des travaux du conseil ainsi que des procédures de contrôle interne mises en place par la société ».
Le présent rapport concerne la société-mère et l’ensemble des sociétés du Groupe entrant dans le périmètre de consolidation.

Strong growth in Revenues in the 3rd quarter

Vétoquinol recorded strong growth in the 3rd quarter of 2009, despite an unfavourable exchange rate effect. The strength in sales was due to a combination of the contribution of acquisitions in Italy and India and sustained organic growth.

Vétoquinol posts resilient results in the first half of 2009 and continues to pursue its international growth

The Board of Directors of Vétoquinol, meeting on August 27, reviewed the group’s business and approved the group’s interim 2009 financial statements.